Training and Resources
Prescribing Information (Great Britain) & Prescribing Information (Northern Ireland) [External links]
KEYTRUDA® (pembrolizumab) in head and neck squamous cell carcinoma (HNSCC)
PD-L1 testing and CPS interpretation in HNSCC
More information about KEYTRUDA® (pembrolizumab) in HNSCC
By clicking this link you will be taken to an MSD promotional website.
Prescribing Information (Great Britain) & Prescribing Information (Northern Ireland)
By clicking the links above you will leave the MSD Connect website and be taken to the emc PI portal website